Minimum Criteria for NIV in Type 2 Respiratory Failure
NIV should be started when a pH <7.35, a PaCO₂ of ≥6.5 kPa (≥48.8 mmHg) and respiratory rate >23 breaths/min persists or develops after an hour of optimal medical therapy. 1
Indications for NIV in Type 2 Respiratory Failure
NIV is indicated in the following scenarios of type 2 respiratory failure:
Primary indications:
- COPD with respiratory acidosis (pH 7.25-7.35)
- Hypercapnic respiratory failure due to chest wall deformity (scoliosis, thoracoplasty)
- Neuromuscular diseases with hypercapnia
- Obesity hypoventilation syndrome with acute hypercapnic respiratory failure
Assessment parameters:
- Arterial blood gas showing pH <7.35
- PaCO₂ ≥6.5 kPa (≥48.8 mmHg)
- Respiratory rate >23 breaths/min
- Persistence of these parameters after 60 minutes of optimal medical therapy
Decision Algorithm for NIV Initiation
Initial assessment:
- Measure arterial blood gases in patients with acute breathlessness
- Identify type 2 respiratory failure (PaO₂ <8 kPa and PaCO₂ >6 kPa)
Optimization phase (60 minutes):
- Provide controlled oxygen therapy targeting SpO₂ 88-92%
- Administer appropriate medical treatment based on underlying condition
- Repeat arterial blood gas after 60 minutes
Decision point:
- If pH normalizes: continue medical therapy
- If pH <7.35, PaCO₂ ≥6.5 kPa, and RR >23: initiate NIV
- For PaCO₂ between 6.0-6.5 kPa: consider NIV (lower grade recommendation) 1
Contraindications to NIV
NIV should not be used in patients with:
Special Considerations
Severity-based approach:
Monitoring requirements:
- Continuous monitoring of respiratory rate, SpO₂, and heart rate
- Repeat arterial blood gas analysis within 1-4 hours of NIV initiation
- Assessment of patient comfort and synchrony with ventilator
Success predictors:
- Improvement in pH and/or respiratory rate within 1-4 hours
- Reduction in PaCO₂ levels
- Improved patient comfort and reduced work of breathing 2
Implementation Requirements
For effective NIV service, minimum facilities required include:
- A consultant/physician committed to developing an NIV service
- Trained nurses on a respiratory ward, high dependency unit, or ICU
- ICU backup for patients who don't improve on NIV
- Appropriate non-invasive ventilator and selection of masks 1
Common Pitfalls to Avoid
Delayed initiation: Waiting too long to start NIV can lead to worsening acidosis and respiratory muscle fatigue, reducing chances of success.
Inappropriate patient selection: Using NIV in contraindicated scenarios (impaired consciousness, copious secretions) increases risk of failure.
Inadequate monitoring: Failure to reassess blood gases after initiation may miss early signs of treatment failure.
Mask-related issues: Poor mask fit leading to excessive leaks can compromise ventilation effectiveness.
Insufficient pressure settings: Using inadequate inspiratory pressures may fail to effectively reduce PaCO₂ levels and work of breathing.
NIV has been shown to reduce mortality, decrease need for intubation, and shorten hospital stays when appropriately applied in type 2 respiratory failure 2, 4. Early application of NIV before severe acidosis develops is associated with better outcomes and faster improvement in arterial blood gases 5.